ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
5,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
6,1,Pulmonary arterial wedge pressure increased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
7,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
8,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
9,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
10,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,Y
12,1,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
12,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
13,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
14,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
15,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
16,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
16,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
17,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
17,2,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
18,1,Gravitational oedema,Oedema NEC,General system disorders NEC,Genrl,N
18,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
19,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
19,2,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
20,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
20,2,Headache,Headaches NEC,Headaches,Nerv,N
21,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
21,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
22,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
22,2,Headache,Headaches NEC,Headaches,Nerv,N
22,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
23,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
24,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
25,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
25,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
25,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
26,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
26,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
26,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
27,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
28,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
29,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
30,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
31,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
32,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
33,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
33,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
34,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
34,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
34,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
35,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
37,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
38,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
39,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
39,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
39,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
40,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
41,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
42,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
43,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
44,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
45,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
46,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
47,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
47,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
48,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
49,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
49,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
49,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
50,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
50,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
51,1,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
51,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
51,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
51,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
51,5,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
52,1,Central cord syndrome,Spinal cord injuries NEC,Injuries NEC,Inj&P,N
52,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
52,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
53,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
53,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
54,1,Cerebral haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
54,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
54,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
55,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
55,2,Uterine rupture,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
56,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
56,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
56,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
57,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
57,2,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
57,3,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
57,4,Cerebral ischaemia,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
57,5,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
57,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
57,7,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
57,8,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
57,9,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
57,10,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
57,11,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
57,12,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
57,13,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
57,14,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
58,1,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
58,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
58,3,Hyperlactacidaemia,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
58,4,Hypoxic-ischaemic encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
58,5,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
58,6,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
58,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
58,8,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
59,1,Solar urticaria,Urticarias,Angioedema and urticaria,Skin,N
60,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
60,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
60,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
61,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
62,1,Brain herniation,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
62,2,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
62,3,Coma,Coma states,Neurological disorders NEC,Nerv,N
62,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
62,5,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
62,6,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
62,7,Reversible cerebral vasoconstriction syndrome,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
62,8,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
63,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
64,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
65,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
65,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
65,3,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
65,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
